chronic renal failure. End-stage renal disease
Conditions
Interventions
Intervention 1: Fourth intervention (TENS placebo): TENS is turned off and researcher place TENS electrodes with 6 centimeter distance from each other on the skin near the location of insertion of art
Placebo
Treatment - Devices
Treatment - Drugs
Fourth intervention (TENS placebo): TENS is turned off and researcher place TENS electrodes with 6 centimeter distance from each other on the skin near the location of insertion of arterial needle. On
First intervention (TENS): TENS electrodes are placed on the skin with 6 centimeter distance from each other near the location of insertion of arterial needle by researcher. Then the TENS is turned on
Second intervention (lidocaine placebo spray): Lidocaine placebo spray is water that is filled in emptied lidocaine spray bottle. 2 puffs are used from distance 5 centimeter on the skin in location of
Third intervention (lidocaine spray): 2 puffs of lidocaine 10% spray (each puff include 10mg lidocaine) are used from distance 5 centimeter on the skin in location of insertion of arterial needle by r
Sponsors
Semnan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
10 Years to 100 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: (1) The patient be alert, (2) The patient does not intake analgesic and narcotic drugs before 6 hours, (3) Not to have any pain in other parts of body, (4) Not to have internal cardiac pacemaker, (5) The patient must have arterio-venous fistula for veonous access. Exclusion criteria: (1) To attend the study is completely optional, So the patient can avoid from study whenever he/she want, without any change in personnel’s behavior or care, (2) At the first action, if the patient 's vessels are not achievable , he/she is omitted from study, (3) patients who are in the low consciousness and cognition condition and could not answer the questions, (4) If the patient is transferred to other centers during studying.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intensity pain. Timepoint: One minute after entering the arterial needle. Method of measurement: Numeric Pain Intensity Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNahid Hoshmand Motlagh
Semnan University Of Medical Sciences
Outcome results
None listed